Scpharmaceuticals Inc
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. Show More...
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 3.64 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.94 -2.18 -8.04 -1.59 -1.77 -1.65 Dividends USD Payout Ratio % * Shares Mil 11.0 11.0 3.0 19.0 19.0 19.0 Book Value Per Share * USD 1.06 4.49 2.98 2.06 Free Cash Flow Per Share * USD -5.56 -1.56 -1.15 Return on Assets % -569.77 -117.15 -29.76 -27.51 -38.58 -37.33 Financial Leverage (Average) 1.13 1.19 1.5 1.46 Return on Equity % -69.11 -31.87 -50.72 -49.99 Return on Invested Capital % -53.24 -28.93 -40.67 -39.11 Interest Coverage -2.74 -28.88 -19.56 -17.67 -14.31 Current Ratio 0.91 10.64 24.12 13.77 14.44 16.96 Quick Ratio 0.84 10.61 23.93 13.48 13.93 16.22 Debt/Equity 0.09 0.1 0.39 0.36